期刊文献+

伽玛刀治疗对胰腺癌患者外周T淋巴细胞亚群的影响 被引量:3

Clinical analysis of immunological effects on pancreatic cancer patients by γ-knife therapy
下载PDF
导出
摘要 目的研究胰腺癌患者伽玛刀治疗前后外周血白细胞、淋巴细胞及T淋巴细胞亚群的变化。方法观察20例胰腺癌患者外周血白细胞、淋巴细胞变化,并与20例健康人对照,采用流式细胞术检测伽玛刀治疗前后外周血CD4+,CD8+,CD4+/CD8+,CD4+CD25+变化。结果胰腺癌患者外周血淋巴细胞及CD4+、CD8+值低于对照组(P<0.01),伽玛刀治疗前后胰腺癌患者CD4+、CD8+含量差异具有统计学意义(P<0.05),伽玛刀治疗前后CD4+/CD8+、CD4+CD25+含量差异无统计学意义(P>0.05)。结论胰腺癌患者存在T淋巴细胞免疫功能低下,抗肿瘤免疫反应差,伽玛刀治疗使患者CD4+、CD8+T淋巴细胞进一步减少,提示伽玛刀治疗中应辅以免疫调节剂以提高临床疗效。 Objective To study the alteration in number of leucocytes,lymphocytes and the immunological function change of T cell in patients with pancreatic cancer after γ-knife therapy.Methods The peripheral blood samples were collected from 20 patients with pancreasis carcinoma and 20 healthy controls.The cell number of leucocytes and lymphocytes was studied by blood RT,the population of CD4+,CD8+,CD4+/CD8+,and CD4+CD25+ were evaluated by using a flow cytometry.Results The total numbers of lymphocytes were lower than those of the healthy controls.The percentages of CD4+ and CD8+ T cell were lower than those of the healthy controls.These differences were of statistical significance(P0.01).After γ-knife therapy,the differences of the proportions of CD4+ and CD8+T cell were of statistical significance(P0.05).The CD4+/CD8+ ratios and the percentages of CD4+CD25+ were not statistically significant(P0.05).Conclusion Pancreasis patients have a cellular immune dysfunction and a poor anti-tumor immune response.The percentages of CD4+ and CD8+ T cell were lower after γ-knife therapy,which suggested that during the γ-knife therapy we should add immune regulative drug to improve therapeutic effect.
机构地区 解放军
出处 《东南国防医药》 2012年第2期129-131,共3页 Military Medical Journal of Southeast China
关键词 伽玛刀 胰腺癌 免疫 外周血淋巴细胞 gamma rays pancreatic cancer immuonology the cell number of leucocytes
  • 相关文献

参考文献13

  • 1王国江,高泽立.胰腺癌的生物治疗研究进展[J].世界华人消化杂志,2008,16(1):56-61. 被引量:2
  • 2陈庆丰,唐顺国,高宏伟,朱义文.立体定向放疗联合吉西他滨治疗胰腺癌56例[J].东南国防医药,2009,11(3):241-243. 被引量:3
  • 3邢爱民,孙玉凤,陈玉凤.肺癌患者外周血T淋巴细胞亚群变化及其临床意义[J].肿瘤学杂志,2004,10(3):173-174. 被引量:4
  • 4Doherty DG,Ofarrelly C. Innate and adaptive lymphoid cells in the human liver[J].Immunological Reviews,2000,(04):5-20.
  • 5Horwitz DA,Zheng SG,Gray JD. The role of the combination of IL2 and TGF heta or IL10 in the generation and function of CD4 + CD25+ and CD8+ regulatory T cell subsets[J].Journal of Leukocyte Biology,2003,(04):471-478.doi:10.1189/jlb.0503228.
  • 6Cederbom L,Hall H,Ivvars F. CD4+CD25+regulatory T cells down regulate to stimulatory molecules on antigen-presenting cells[J].European Journal of Immunogenetics,2000,(06):1538-1543.
  • 7Kursar M,Bonhagen K,Fensterle J. Regulatory CD4+ CD25+T cells restrict memory CD8+T cell responses[J].Journal of Experimental Medicine,2002,(12):1585-1592.
  • 8Azuma T,Takahashi T,Kunisato A. Human CD4+CD25+ regulatory T cells suppress NKT cell functions[J].Cancer Research,2003,(15):4516-4520.
  • 9Ichilara F,Kono K,Takahashi A. Increased populations of regulatory T cells in peripheral blood and TILs in patients with gastric and esophageal cancers[J].Clinical Cancer Research,2003,(12):4404-4408.doi:10.1007/s00702-010-0406-7.
  • 10Woo EY,Yeh H,Chu CS. Cutting edge:regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation[J].Journal of Immunology,2002,(09):4272-4276.

二级参考文献27

共引文献16

同被引文献37

  • 1朱世杰,贾立群,李佩文.艾迪注射液抑制肿瘤新生血管形成的实验研究[J].中国实验方剂学杂志,2008,14(11):55-57. 被引量:27
  • 2罗军,靳风烁.肿瘤的免疫逃逸机制研究进展[J].肿瘤防治研究,2004,31(7):454-456. 被引量:11
  • 3吴铁鹰,刘永兰,张峻青,肖振中,黄玉胜,张改英,曹晶杰,韩小龙.体部伽玛刀治疗Ⅰ、Ⅱ期非小细胞肺癌疗效分析[J].中国临床实用医学,2014(2):6-8. 被引量:2
  • 4Appay V,van Lier RA,Sallusto F,et al.Phenotype and function of human T lymphocyte subsets:consensus and issues[J].Cytometry A,2008,73(11):975-983.
  • 5Yu QM,Yu CD,Ling ZQ.Elevated circulating CD19 lymphocytes predict survival advantage in patients with gastric cancer[J].Asian Pac J Cancer Prev,2012,13(5):2219-2224.
  • 6Gopalakrishnan S,Sen S,Adhikari JS,et al.The role of T-lymphocyte subjects and interleukin-5 blood levels among Indian Subjects with autoimmune thyroid disease[J].Hormones(Athens),2010,9(1):76-81.
  • 7Harrington LE,Hatton RD,Mangan PR,et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nat Immunol,2005,6(11):1123-1132.
  • 8Dolff S,Abdulahad WH,Arends S,et al.Urinary CD8+ T cell counts discriminate between active and inactive lupus nephritis[J].Arthritis Res Ther,2013,15(1):36-37.
  • 9Felga G,Evangelista AS,Salvalaggio PR,et al.Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria[J].Transplant Proc,2012,44(8):459-2461.
  • 10Li Rui, Chenwei-chang, Wang Wei-peng, et al. Antioxidant activity of astragalus polysaccharides and antitumouractivity of the polysac- charides and siRNA [ J ]. Carbohydrate polymers, 2010,82 ( 2 ) : 240-244.

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部